NL

Business Context and Reporting Period

Company: NL Industries, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 1997
Operations: The Company operates through two primary segments: Kronos, Inc. (titanium dioxide pigments) and Rheox, Inc. (specialty chemicals). The Company is controlled by affiliates of Contran Corporation, which hold approximately 74% of outstanding common stock.

Key Financial Metrics

Segment Performance (Nine Months 1997):

• Kronos (TiO2): Net sales of $629.1 million; Operating income of $50.4 million.
• Rheox (Specialty Chemicals): Net sales of $111.3 million; Operating income of $34.6 million.

Material Changes vs. Prior Period

• Net Loss vs. Net Income: The Company reported a net loss of $23.7 million for the nine months ended September 30, 1997, compared to a net income of $21.1 million in the same period in 1996. This reversal is primarily due to a $30 million noncash charge recognized in the first quarter of 1997 related to the adoption of SOP No. 96-1 regarding environmental remediation liabilities.
• Revenue: Consolidated net sales decreased 2% to $740.4 million. Kronos sales declined 3% due to an 8% drop in average selling prices, partially offset by a 12% increase in volume. Rheox sales increased 9% driven by higher volumes.
• Operating Income: Consolidated operating income decreased 13% to $85.0 million. Kronos operating income fell 22% due to lower selling prices, while Rheox operating income increased 5%.
• Debt Reduction: Total debt decreased by approximately $73 million compared to year-end 1996, following a refinancing of the Rheox subsidiary and prepayments on Kronos debt.
• Cash Flow: Operating cash flow improved significantly to $70.8 million (up from $38.3 million in 1996), driven largely by a $44.6 million reduction in inventory levels.

Guidance, Outlook, Risks, and Contingencies

Management Commentary and Outlook:

• Kronos: Management expects full-year 1997 operating income to exceed 1996 levels, citing anticipated price increases in the fourth quarter and strong demand in Europe.
• Liquidity: The Company refinanced Rheox in January 1997, reducing scheduled debt payments for 1997 and 1998 by $103 million. As of September 30, 1997, the Company had $109 million in available borrowing capacity under existing credit facilities.

Material Risks and Contingencies:

• Environmental Remediation: The Company accrued $136 million for environmental costs. The upper end of the range of reasonably possible costs is estimated at $180 million. A $30 million noncash charge was taken in Q1 1997 to align with new accounting standards.
• Tax Litigation (Germany): Significant tax contingencies remain outstanding. The Company has received assessments totaling DM 130 million ($74 million) and may receive an additional DM 20 million. A lien of DM 100 million ($57 million) was granted on the Nordenham plant. Management believes it will prevail based on recent court precedents but acknowledges uncertainty.
• Lead Pigment Litigation: The Company is a defendant in various personal injury and property damage suits related to lead pigments. No amounts have been accrued as management believes the claims are without merit, though future liability cannot be estimated.

Investor Verification Checklist

• Environmental Accruals: Verify the sufficiency of the $136 million accrual against the $180 million upper-range estimate for remediation costs.
• German Tax Dispute: Monitor the status of the German Supreme Court appeal regarding the trade capital tax base, which could impact the $74 million+ in assessed liabilities.
• Debt Covenants: Confirm continued compliance with financial covenants following the refinancing and debt restructuring.
• Price Realization: Validate management's expectation of TiO2 price increases in Q4 1997 to offset the 8% price decline seen in the first nine months.
• Lead Litigation: Review updates on pending lead pigment lawsuits to ensure no material accruals are required despite current management stance.